Anti-ERBB2/HER2(Marstacimab Biosimilar) Antibody
Product Name :
Anti-ERBB2/HER2(Marstacimab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human ERBB2/CD340/HER2
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-ERBB2/HER2(Marstacimab Biosimilar) Antibody is a biosimilar antibody directed against Human ERBB2/CD340/HER2.{{2763252-25-9} site|{2763252-25-9} Biological Activity|{2763252-25-9} In Vivo|{2763252-25-9} supplier} | Isotype: Human IgG1 | Conjugate: Unconjugated | Specificity: Human ERBB2/CD340/HER2 | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.{{1092351-10-4} web|{1092351-10-4} Protocol|{1092351-10-4} References|{1092351-10-4} supplier} 5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-ERBB2/HER2(Marstacimab Biosimilar) Antibody is a biosimilar antibody directed against Human ERBB2/CD340/HER2.PMID:30480946
Immunogen:
Host :
Isotype:
Human IgG1
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.